Marshall Wace, LLP Conmed Corp Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Conmed Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 7,401 shares of CNMD stock, worth $520,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,401
Previous 75,415
90.19%
Holding current value
$520,734
Previous $5.23 Million
89.82%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding CNMD
# of Institutions
307Shares Held
33.1MCall Options Held
123KPut Options Held
24.2K-
Black Rock Inc. New York, NY4.99MShares$351 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.53MShares$248 Million0.0% of portfolio
-
Earnest Partners LLC Atlanta, GA2.78MShares$196 Million0.91% of portfolio
-
Capital Research Global Investors Los Angeles, CA1.54MShares$109 Million0.02% of portfolio
-
Bank Of America Corp Charlotte, NC1.37MShares$96.4 Million0.01% of portfolio
About CONMED Corp
- Ticker CNMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,482,400
- Market Cap $2.14B
- Description
- CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...